We’re proud to celebrate a remarkable milestone from our portfolio company Remilk, which has just launched The New Milk in collaboration with Gad Dairies, marking the first commercial rollout of its precision-fermented milk.
Fresh Fund was Remilk’s first investor, leading the company’s pre-seed round at its inception five years ago. It was one of those crazy bets - bold, uncertain, and surrounded by skeptics (and still is). What began as an ambitious idea by Aviv Wolff and Ori Cohavi, PhD, is now a commercial reality, reaching consumers across cafés, restaurants, and soon, retail shelves.
The road here was anything but simple: years of R&D filled with breakthroughs and setbacks, moments of doubt, strategic pivots, and above all - relentless perseverance. And while there’s still a long journey ahead, this milestone deserves to be celebrated. It’s a testament to the founders’ vision, resilience, and the phenomenal team they’ve built.
Investing in deep-tech ventures like Remilk is never easy. The cycles are long, capital is demanding, and progress rarely follows a straight line. A company like Remilk is a true moonshot. Many stars must align for it to succeed. It’s hard, it’s risky - but when it works, it can transform an entire industry.
This moment marks not only a breakthrough for Remilk, but a powerful reminder for us as a fund of why we do what we do, and why we’ll keep daring to back bold ideas early.
*There’s been plenty of buzz around Remilk’s New Milk launch. You can read more in the recent coverage here, here, and here, with even more pieces here and here.
Cellergy - Cellergy is pioneering a breakthrough in mitochondrial transplantation therapy, harnessing young, healthy mitochondria to address one of the fundamental drivers of aging and disease - mitochondrial dysfunction. This positions the company at the forefront of next-generation regenerative therapeutics.
Lembas - Lembas develops natural, clinically validated bioactive ingredients for functional foods and supplements, using an AI-powered discovery platform. Its lead product, GLP-1 Edge™, is a food-grade peptide that enhances the body’s GLP-1 response to support appetite regulation and metabolic health. Check out these articles published about the company in Forbes and in FoodNavigator.
Modulight - Modulight is developing a precision neuromodulation platform based on optogenetics to treat severe neurological disorders, including movement disorders, epilepsy, and trigeminal neuropathic pain. Optogenetics enables precise, light-based control of brain activity, offering a groundbreaking new approach to neuromodulation. The company’s technology builds on pioneering research conducted at the Weizmann Institute of Science.
Check out the recent Haaretz feature on light-based therapies highlighting Modulight’s work, as well as the company’s announcement of its $12M Seed round.
PMF Labs - PMF Labs is building a new category in AI-powered hiring, starting with product managers and expanding into a broader talent intelligence platform. The company combines mock interview prep, real-time candidate evaluation, and enterprise-grade screening into a single data-driven engine—turning hiring into a scalable, repeatable science.
Thetis AI - Thetis is developing an AI-powered navigation and speed optimization system designed to optimize fuel consumption and reduce CO₂ emissions for commercial shipping—a sector facing billions in annual fuel costs. Check out this recent Ctech coverage on the company.
Since the start of 2025, we’ve also made 10 new investments in defense and dual-use startups through our new defense-focused vehicle, Fresh Defense. The companies we can mention include Brinker, Fourier Optics, Insignito, Nelysis, SkyPearl, and Starling with the rest still operating in stealth.
Firmus has been acquired by Nemetschek 🍾 Working with Shir Abecasis, CEO and founder of Firmus, has been a true privilege. Her resilience through pivots and challenges perfectly embodies the Fresh Fund model - backing exceptional founders in non-consensus spaces from day one. Congrats to Shir, the entire Firmus team, and all the investors and stakeholders involved!
Gigablue’s CDR methodology has been officially approved. After a rigorous scientific review, Puro.earth has validated the MCFS (Microalgae Carbon Fixation & Sinking) methodology - a major milestone for Gigablue’s verified, scalable, and environmentally safe ocean-based carbon removal solution.
Guardoc won the Catalyst Startup Competition at eCap Summit, one of the leading U.S. healthcare events focused on nursing facility owners.
A major milestone for CarbonBlue: Isometric, one of the world’s leading carbon registries, has certified the Direct Ocean Capture and Storage (DOCS) Protocol. The company also launched Project Midway - the first-ever continuous integration of carbon removal technology within a desalination plant.
ITC’s solution for reducing traffic congestion and its national rollout with Netivei Israel were highlighted by the Israel Ministry of Transport, as hundreds of intersections nationwide transition to smart, AI-powered signal control. Check it out here
Remepy announced a study in Nature’s NPJ Digital Medicine showing that its RMPY-008 digital intervention reduces inflammation, improves brain connectivity, and alleviates depressive symptoms in people with cognitive decline - establishing a new therapeutic modality and advancing its Hybrid Drug™ platform that integrates digital and pharmacological interventions. The company was also named one of TheMarker’s most promising Israeli companies for 2025.
R2 was selected as one of only eight winners of the U.S. Army’s xTechDisrupt competition, out of 375 participating startups. The company won in the Counter-Unmanned Aerial Systems (C-UAS) category. Check out R2’s technology in action, tested by the 1st Cavalry Division, U.S. Army, at the National Training Center in Fort Irwin, California.
Acsense Recognized as a CRN 2025 Stellar Startup for redefining IAM resilience.
Ben Fuxbruner, CEO and Co-founder of Kimba, shared the powerful personal story that led him to found the company after being wounded during his military service. You can also hear Ben’s story and learn more about how Kimba is creating a new category in sleep technology by combining AI, scent, and biometrics in his recent podcast interview.
Tip&Cue has secured a $1.9 million contract from the U.S. Army to advance mission-critical RF Spectrum Intelligence capabilities.
The future is “Multi-Agent”. In this podcast interview, Amos Bar Joseph, CEO of Swan AI, explains how agentic swarms are redefining product velocity, customization, and value creation — and why true agentic software, built as a network of collaborating agents, can outperform SaaS in scale and efficiency. A first-principles look at the future of software architecture.
Wisor just launched a new website that captures its expanding value proposition for freight forwarders. Take a look here.
Fresh Fund is a sector-agnostic first-check fund investing in ambitious Israeli founders. As one of the largest and most active dedicated pre-seed funds in Israel, we love to partner with founders from day zero.
>> Stay in our loop via LinkedIn
It’s never too early to start a conversation about your startup.
No posts
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.